CAPRA-S
ورودیهای بالینی بیمار
حداقل ۰.۱ — حداکثر ۲۰۰ • واحد: ng/mL
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- High risk≥ 6
- Intermediate risk≥ 3
- Low risk≥ 0
The CAPRA-S calculates evaluating lower urinary tract symptoms, nephrolithiasis burden, and prostate cancer risk. Key inputs include psa. Scores guide initiating medical expulsive or alpha-blocker therapy, ordering renal imaging, or scheduling surgical intervention. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Cancer of the Prostate Risk Assessment post-surgical score.
Clinical Indication
The CAPRA-S is indicated for bedside clinical practice to support Cancer of the Prostate Risk Assessment post-surgical score.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with renal colic, hematuria, benign prostatic hyperplasia (BPH), or urogenital malignancies. Clinical application is indicated across Urology clinics, shock wave lithotripsy suites, and acute urologic surgical services.
Limitations & Contraindications
Serum PSA levels can be transiently elevated by acute prostatitis, urinary retention, or recent instrumentation.
Clinical Pearls & Action Plan
Obstructive urolithiasis complicated by upper urinary tract infection represents a surgical emergency requiring urgent decompression.
PSA 0-3 + Gleason 0-3 + margin 0/2 + ECE 0/1 + SVI 0/2 + LNI 0/1; total 0-12.
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| psa | float | Yes | Preoperative PSA(ng/mL) |
| gleason | string | Yes | le6: <=6, 3p4: 3+4, 4p3: 4+3, ge8: 8-10 |
| surgical_margin | string | Yes | Surgical margins: negative, positive |
| extracapsular_extension | string | Yes | Extracapsular extension: yes, no |
| seminal_vesicle_invasion | string | Yes | Seminal vesicle invasion: yes, no |
| lymph_node_invasion | string | Yes | Lymph node invasion: yes, no |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| ≥ 6 | High risk | High risk of recurrence |
| ≥ 3 | Intermediate risk | Intermediate risk |
| ≥ 0 | Low risk | Low risk of recurrence |
Evidence-Based References (EBM)
- Cooperberg MR, Hilton JF, Carroll PR. The CAPRA-S score. Eur Urol. 2011;60(2):327-337.